MicroRNA hsa-miR-4674 in Hemolysis-Free Blood Plasma Is Associated with Distant Metastases of Prostatic Cancer

E. N. Knyazev; T. R. Samatov; K. A. Fomicheva; K. M. Nyushko; B. Ya. Alekseev; M. Yu. Shkurnikov

doi:10.1007/s10517-016-3358-6

MicroRNA hsa-miR-4674 in Hemolysis-Free Blood Plasma Is Associated with Distant Metastases of Prostatic Cancer

作者: Knyazev E.¹, Samatov T.¹, Fomicheva K.², Nyushko K.², Alekseev B.², Shkurnikov M.¹^,2
隶属关系:
1. BioClinicum Research and Development Center
2. National Medical Research Radiology Center
期: 卷 161, 编号 1 (2016)
页面: 112-115
栏目: Article
URL: https://journals.rcsi.science/0007-4888/article/view/237169
DOI: https://doi.org/10.1007/s10517-016-3358-6
ID: 237169

如何引用文章

全文:

开放存取

##reader.subscriptionAccessGranted##
受限制的访问

订阅存取

详细
作者简介
参考
统计

详细

We analyzed microRNA profile in hemolysis-free blood plasma of patients with prostatic cancer. The metastatic form of prostatic cancer was found to be associated with increased levels of hsa-miR-22-3p, hsa-miR-663a, and hsa-miR-4674 in comparison with non-metastatic form. Common candidate target genes of these microRNA include JUNB, KMT2A, and XPO6.